Dose Dependence of Chronic Positive Inotropic Effect of Vesnarinone in Patients With Congestive Heart Failure Due to Idiopathic or Ischemic Cardiomyopathy
Open Access
- 15 September 1996
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 78 (6), 652-656
- https://doi.org/10.1016/s0002-9149(96)00388-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.JCI Insight, 1994
- Validation of a method for noninvasive measurement of central arterial pressure.Hypertension, 1993
- A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failureCardiovascular Drugs and Therapy, 1990
- New Positive Inotropic Agent OPC-8212 Modulates Single Ca2+ Channels in Ventricular Myocytes of Guinea PigJournal of Cardiovascular Pharmacology, 1989
- Sustained inotropic effects of a new cardiotonic agent. OPC‐8212 in patients with chronic heart failureClinical Cardiology, 1989
- Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failureAmerican Heart Journal, 1988
- Pharmacokinetic Profile of OPC‐8212 in Humans: A New, Nonglycosidic, Inotropic AgentThe Journal of Clinical Pharmacology, 1988
- Cardiotonic activity of a new inotropic agent, 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone (OPC-8212), in the dog with and without .BETA.-blocker and Ca++-antagonist pretreatment.Japanese Circulation Journal, 1986
- Acute Hemodynamic Effects of a New Positive Inotropic Agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in Conscious and Anesthetized DogsJournal of Cardiovascular Pharmacology, 1986
- Measurement of absolute left ventricular volume from gated blood pool studies.Cell Metabolism, 1982